6 completed, 3 unknown, 2 recruiting, 1 terminated. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 6, Unknown 3, Recruiting 2, Terminated 1 |
Follow Cataract Surgery: new trials by email Literature Review of Cataract Surgery trials Research Report on Cataract Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Lacrifill Lacrifill, Saline - Dry Eye, Ocular Surface Disease | Phase 4 | Recruiting | Eye Research Associates, LLC | 40 | 2026-09-02 | 2026-09-25 |
| Oral vs IV Sedation for Cataract Surgery in Older Adults Alprazolam, Midazolam - Cataract Surgery, Sedation | Phase 4 | Completed | University of California, San Francisco | 20 | 2025-08-12 | 2026-04-27 |
| Remimazolam for Cataract Surgery Remimazolam, Midazolam - Cataract Surgery, Cognitive Impairment | Phase 4 | Recruiting | University of California, Los Angeles | 120 | 2025-03-10 | 2025-03-19 |
| Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN) Nepafenac Ophthalmic, Dexamethasone Ophthalmic - Cataract Surgery | Phase 4 | Unknown | Oslo University Hospital | 500 | 2022-11-25 | 2022-12-01 |
| Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy Dextenza 0.4Mg Ophthalmic Insert - Dry Eye Disease, Cataract Surgery | Phase 4 | Unknown | Prism Vision Group | 35 | 2021-01-01 | 2020-12-11 |
| Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery Omidria, Dextenza (dexamethasone ophthalmic insert) 0.4mg, Dexycu, 9% Intraocular Suspension - Cataract Surgery | Phase 4 | Completed | Silverstein Eye Centers | 15 | 2019-12-10 | 2023-06-15 |
| Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study. Dropless Therapy, Usual Care - Cataract Surgery | Phase 4 | Terminated | PeriPharm | 80 | 2018-08-15 | 2021-09-21 |
| Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery FID 112903 (SYSTANE® ULTRA Lubricant Eye Drops) plus standard of care, Standard of Care - Dry Eye, Cataract Surgery | Phase 4 | Completed | Alcon Research | 40 | 2010-09-01 | 2016-11-18 |
| 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery besivance, vigamox - Corneal Health, Cataract Surgery | Phase 4 | Completed | Ophthalmology Consultants, Ltd. | 60 | 2010-09-01 | 2011-10-19 |
| Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Pred Forte, Lotemax - Pseudophakia, Cataract Surgery | Phase 4 | Unknown | Innovative Medical | 100 | 2010-09-01 | 2012-06-14 |
| A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery Prednisolone acetate - Cataract Surgery | Phase 4 | Completed | Novartis | 62 | 2004-08-17 | 2017-03-01 |
| Therapeutic Variables in Cataract Surgery Gatifloxacin, Ketorolac LS, Pred Forte - Cataract Surgery | Phase 4 | Completed | Innovative Medical | 2007-08-21 |
Dry Eye Syndromes (3) · Cataract (1) · Cognitive Dysfunction (1) · Corneal Diseases (1) · Inflammation (1) · Patient Satisfaction (1) · Pseudophakia (1)
Eye Diseases (5) · Lacrimal Apparatus Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Cognition Disorders (1) · Health Behavior (1) · Lens Diseases (1) · Mental Disorders (1) · Neurocognitive Disorders (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Treatment Adherence and Compliance (1)
prednisolone acetate (3) · Calcium Dobesilate (2) · Midazolam (2) · Moxifloxacin (2) · Alprazolam (1) · Gatifloxacin (1) · Loteprednol Etabonate (1) · Methylprednisolone (1) · Sodium Chloride (1) · Standard of Care (1) · Triamcinolone Acetonide (1) · besifloxacin (1) · nepafenac (1) · remimazolam (1)
Innovative Medical (2) · Alcon Research (1) · Eye Research Associates, LLC (1) · Novartis (1) · Ophthalmology Consultants, Ltd. (1) · Oslo University Hospital (1) · PeriPharm (1) · Prism Vision Group (1) · Silverstein Eye Centers (1) · University of California, Los Angeles (1) · University of California, San Francisco (1)
United States (7) · Canada (1) · Norway (1)
William Trattler, MD (2) · Bonnie Henderson, MD (1) · Catherine L Chen, MD, MPH (1) · Cynthia Matossian, MD (1) · John Hovanesian, MD (1) · Joseph Gira, MD (1) · Olav Kristianslund, MD PhD (1) · Ranjan Maholtra, MD (1) · Zhuang Fang, MD (1)